SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
By: marketsandmarkets.com
Publishing Date: July 2012
Report Code: BT 1764
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
SNP analysis has become an appealing and convenient method to study DNA sequence variations. The market is likely to notice a double digit growth rate as more microarrays with more DNA probes enter the market.
Whole genome SNP analysis will be the major growth driver for this market. Lower multiplexing products, part of clinical trials are likely to account for more of the growth. Drop in prices will further boost the market with increased demand and adoption rates. Affymetrix, Applied Biosystems (ABI) (Life Technologies), and Illumina are the major players in this market.
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement
